Buspirone Hydrochloride Tablet
Product Images NDC 71610-165

5 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 71610-165). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 5 mg (71610 0165 53)

Bottle Label 5 mg (71610 0165 53)
Buspirone Hydrochloride USP 5 mg oral tablet bottle label containing 60 tablets. The label includes storage instructions, repackager Aphena Pharma Solutions - Tennessee, LLC, and manufacturer Intas Pharmaceuticals Limited, Ahmedabad, India. The product is prescription only and displays barcodes and NDC number 71610-0165-53.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Dosage Table (Buspirone Fig 1)

Dosage Table (Buspirone Fig 1)
An instructional diagram showing tablet fractions to take when prescribed either a 15 mg or 30 mg Buspirone Hydrochloride tablet. It illustrates how to achieve doses of 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, and 30 mg by splitting tablets into halves or thirds, with corresponding visual tablet segments labeled.*
FDA Label Image

Quadrisect Photo (Buspirone Fig 2)

Quadrisect Photo (Buspirone Fig 2)
Illustration showing how to split buspirone hydrochloride tablets into halves, specifically a 15 mg tablet and a 30 mg tablet, each being broken carefully by hand along the scored line.*
FDA Label Image

Buspirone Structural Formula (Buspirone Str)

Buspirone Structural Formula (Buspirone Str)
Chemical structure diagram of Buspirone Hydrochloride, showing its molecular arrangement with a piperazine ring and imidazopyridine moiety, ending with the hydrochloride (HCl) salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.